Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Assets Average: 2020-2025

Historic Assets Average for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $667.9 million.

  • Oncology Institute's Assets Average fell 1568.2% to $667.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $667.9 million, marking a year-over-year decrease of 1568.2%. This contributed to the annual value of $191.0 million for FY2024, which is 1888.87% down from last year.
  • Per Oncology Institute's latest filing, its Assets Average stood at $667.9 million for Q3 2025, which was down 1568.2% from $685.6 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Assets Average peaked at $989.9 million during Q2 2023, and registered a low of $667.9 million during Q3 2025.
  • Over the past 5 years, Oncology Institute's median Assets Average value was $836.9 million (recorded in 2024), while the average stood at $830.4 million.
  • As far as peak fluctuations go, Oncology Institute's Assets Average soared by 1639.65% in 2023, and later crashed by 1894.87% in 2024.
  • Quarter analysis of 5 years shows Oncology Institute's Assets Average stood at $826.7 million in 2021, then increased by 10.4% to $912.6 million in 2022, then increased by 0.63% to $918.4 million in 2023, then fell by 17.87% to $754.3 million in 2024, then dropped by 11.45% to $667.9 million in 2025.
  • Its Assets Average stands at $667.9 million for Q3 2025, versus $685.6 million for Q2 2025 and $715.8 million for Q1 2025.